An IL-1 inhibitor combined with compound betamethasone as first-line therapy for acute gouty arthritis: an open-label, single-arm, exploratory cinical trial

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 243a120e7f75678511c0709bd2970cbf345d1ba2
First added on: May 09, 2026